Patient-friendly
cream and foam
formulations

Moisturizing properties^1,10,12-14*

• A novel, water-based emollient formulation

Drug delivery without disrupting
the skin barrier^1,2,12,14,15

• No penetration enhancers
• No ceramide-stripping properties

No known sensitizers or irritants^1,2

• No fragrances, ethanol, or propylene glycol

Low rates of stinging or burning^5†

Mild to Moderate
Atopic Dermatitis
Cream 0.15%
Down to 6 years old

Seborrheic
Dermatitis
Foam 0.3%
Down to 9 years old

Plaque
Psoriasis
Foam 0.3%
Down to 12 years old

Plaque
Psoriasis
Cream 0.3%
Down to 6 years old

^*Demonstrated in clinical trials of patients with atopic dermatitis.

^†Low rates of hot, tingling/stinging sensation reported in patient-rated tolerability assessments 10–15 minutes after first application. For atopic dermatitis: 1.6% with ZORYVE (n=883) vs 2.0% with vehicle (n=451). For seborrheic dermatitis in STRATUM: 1.3% with ZORYVE (n=304) vs 1.3% with vehicle (n=152). For plaque psoriasis foam in ARRECTOR: 0.4% with ZORYVE foam (n=280) vs 1.4% with vehicle (n=148). For plaque psoriasis cream: 0.4% with ZORYVE cream (n=562) vs 0.0% with vehicle (n=301).